Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Pfizer Inc.
IndexDJIA S&P500 P/E19.09 EPS (ttm)1.59 Insider Own0.02% Shs Outstand6.34B Perf Week3.09%
Market Cap192.45B Forward P/E13.56 EPS next Y2.24 Insider Trans-3.72% Shs Float6.34B Perf Month5.24%
Income10.37B PEG6.16 EPS next Q0.55 Inst Own71.90% Short Float1.10% Perf Quarter2.15%
Sales50.33B P/S3.82 EPS this Y37.50% Inst Trans0.26% Short Ratio3.07 Perf Half Y-3.44%
Book/sh12.03 P/B2.52 EPS next Y-0.36% ROA17.20% Target Price34.02 Perf Year8.63%
Cash/sh5.37 P/C5.65 EPS next 5Y3.10% ROE38.70% 52W Range27.33 - 32.67 Perf YTD0.80%
Dividend1.04 P/FCF18.01 EPS past 5Y6.80% ROI10.50% 52W High-7.09% Beta0.69
Dividend %3.43% Quick Ratio2.40 Sales past 5Y1.30% Gross Margin81.30% 52W Low11.06% ATR0.36
Employees77700 Current Ratio2.70 Sales Q/Q-1.50% Oper. Margin33.40% RSI (14)65.37 Volatility1.28% 1.06%
OptionableYes Debt/Eq0.49 EPS Q/Q-10.00% Profit Margin59.30% Rel Volume1.15 Prev Close30.05
ShortableYes LT Debt/Eq0.42 EarningsJul 29 BMO Payout22.50% Avg Volume22.65M Price30.35
Recom2.30 SMA203.45% SMA503.17% SMA2000.51% Volume26,101,868 Change1.00%
02-Jul-13Downgrade Standpoint Research Hold → Sell $24
15-Apr-13Reiterated Barclays Equal Weight $25 → $32
30-Jan-13Reiterated UBS Buy $29 → $31
30-Jan-13Reiterated Argus Buy $28 → $32
22-Jan-13Reiterated Barclays Equal Weight $24 → $25
27-Nov-12Downgrade MKM Partners Buy → Neutral $29 → $25
05-Oct-12Reiterated MKM Partners Buy $27 → $29
01-Nov-11Downgrade Standpoint Research Buy → Hold
07-Oct-11Initiated MKM Partners Buy $20.50
14-Sep-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
10-Aug-11Upgrade Argus Hold → Buy $21
05-Aug-11Upgrade Standpoint Research Hold → Buy $21
14-Mar-11Downgrade Standpoint Research Buy → Hold
03-Nov-10Downgrade Argus Buy → Hold
21-May-10Initiated Jefferies Buy $17.80
16-Dec-09Initiated UBS Buy
27-Apr-09Initiated Standpoint Research Buy $20
12-Feb-09Upgrade Leerink Swann Mkt Perform → Outperform
09-Feb-09Upgrade UBS Neutral → Buy
02-Feb-09Upgrade Credit Suisse Neutral → Outperform
17-Sep-14 06:15PM  Isis Pharmaceuticals CEO: Not changing name, terrorists c... CNBC
04:06PM  The 4 Stocks That Boosted the Market at 24/7 Wall St.
02:25PM  3 Huge Stocks on Traders' Radars: SHLD, PFE, GILD at TheStreet
16-Sep-14 03:52PM  Apple, IBM buying back billions in stock: WSJ Yahoo Finance
02:12PM  Alzheimer's drug fight CNBC
15-Sep-14 11:41AM  These Two Companies Could Be Pfizer's Top Targets at Barrons.com
09:30AM  A Fabulous Pharma ETF ETF Trends
08:50AM  Takeover Panel proposes tougher rules for deal promises at Financial Times
06:27AM  U.K. Merger Panel Seeks Tougher Rules on Job Promises at Bloomberg
12-Sep-14 05:05PM  Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor Reuters
01:14PM  Pfizer CEO is Still Weighing Inversion Deals at The Wall Street Journal
11:32AM  Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies at TheStreet
11:24AM  $250 Billion in Biotech Drug Savings on Brink of Arrival at Bloomberg
11-Sep-14 04:15PM  Seattle Genetics-Genmab Expand Deal for Antibody Platform Zacks
02:28PM  Pfizer says 'window still open' for tax inversions at Financial Times
01:50PM  5 Toxic Stocks to Sell Now at TheStreet
12:12PM  7 Pictures Are Worth 20 Prudent Speculator Stock Picks at Forbes
05:00AM  Magic Mushrooms Help Smokers Kick Habit in Small Study at Bloomberg
10-Sep-14 11:05AM  The Tax Inversion Rush--In One Handy Graphic at Forbes
10:33AM  Pfizer Inc. Trying To Claw Its Way Back Up After Pullback Benzinga
06:41AM  Facebook More Valuable Than IBM at 24/7 Wall St.
09-Sep-14 12:31PM  Martoma's Nine-Year Sentence Reflects Outsized Insider Trading Gains at Forbes
12:08PM  [video] As Life Expectancies Rise, Death Care Stocks Offer Opportunities at TheStreet
06:50AM  [video] Solid Venture's quest to fight DMD at CNBC
08-Sep-14 06:21PM  SAC's Martoma gets 9 years prison for insider trading Reuters
05:06PM  SAC's Martoma gets 9 years prison for insider trading Reuters
04:47PM  SAC's Martoma gets 9 years prison for record insider trading scheme Reuters
04:25PM  Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq Zacks
08:48AM  J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig at TheStreet
05-Sep-14 02:12PM  Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units Zacks
12:51PM  Corporate America's Hunt For Lower Taxes Won't End With Burger King And Tim Horton's at Forbes
12:01AM  Obamacare Effect Linked to Lower Medical Cost Estimates Bloomberg
04-Sep-14 04:33PM  Merck PD-1 Inhibitor Approved For Skin Cancer at Investor's Business Daily
02:01PM  U.S. judge won't toss insider trading conviction of SAC's Martoma Reuters
12:50PM  FDA Lowdown on 'Low T' Drugs: Little Evidence to Support Widespread Use at The Wall Street Journal
11:23AM  AstraZeneca Called the White House to say: Stop Those Tax Inversions!! at The Wall Street Journal
08:06AM  Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists at Forbes
03-Sep-14 08:38PM  [$$] How Astra Helped Fuel Obama's Attack on Tax Deals at The Wall Street Journal
05:57PM  [$$] How Astra Helped Fuel Obama's Attack on Tax Deals at The Wall Street Journal
05:07PM  [$$] AstraZeneca Targeted Washington to Fend Off Pfizer at The Wall Street Journal
11:00AM  [video] Beyond Lipitor at CNBC
10:32AM  Sanofi: First Heart Disease, Now Dengue Fever at Barrons.com
10:00AM  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
08:30AM  Protalix Biotherapeutics Inc Corporate Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs scheduled for 8:30 am ET today CCBN
02-Sep-14 04:51PM  Stock buybacks blamed for lack of U.S. prosperity at MarketWatch
08:59AM  Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors Reuters
08:21AM  Can The Dutch Biotech Dezima Really Impact Heart Disease With Its HDL-Raising Drug? at Forbes
01-Sep-14 09:05PM  Public Pension Funds Stay Mum on Corporate Expats at New York Times
30-Aug-14 05:15AM  Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE) Business Wire
29-Aug-14 05:10PM  Pfizer's C. Difficile Vaccine Gets Fast Track Status Zacks
04:14PM  Partnering With Big Pharma, Parexel Hits Its Stride at Investor's Business Daily
04:00PM  Protalix/Pfizer's Elelyso Approved in Pediatric Patients Zacks
02:37PM  Investors Bet AstraZeneca Megamerger Could Live Again at Bloomberg
10:16AM  Dow 30 Stock Roundup: UTX Reiterates Guidance, BA Wins $8.8B Order Zacks
10:13AM  InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® PR Newswire
28-Aug-14 06:42PM  Amgen edges up on trial results Investor's Business Daily
05:03PM  Fed Chair Yellen's assets up 8% during 2013 at USA TODAY
03:56PM  AstraZeneca Pops on Possibility of Another Pfizer Bid at The Wall Street Journal
01:15PM  Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease Business Wire
09:40AM  [$$] Pfizer Vaccine Candidate Gets Fast Track at The Wall Street Journal
09:13AM  [$$] Pfizer Vaccine Candidate Gets Fast Track at The Wall Street Journal
08:45AM  [$$] Pfizer Vaccine Candidate Gets Fast Track at The Wall Street Journal
08:00AM  Pfizers Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation Business Wire
06:34AM  French leader banks on free market to save economy AP
27-Aug-14 06:15PM  Your first trade for Thursday at CNBC
06:00PM  Pfizer and Merck Collaborate to Develop Lung Cancer Therapy Zacks
05:58PM  [video] Fast Money Final Trade: PFE, GDX, DOW, WFT at CNBC
04:11PM  Stocks little moved as S&P 500 ends above 2,000 again at CNBC
04:04PM  Stocks little moved as S&P 500 ends above 2,000 again at CNBC
03:15PM  US stocks fluctuate; S&P 500 near milestone at CNBC
02:03PM  US stocks fluctuate; S&P 500 near milestone at CNBC
01:11PM  [video] Options Insight: Unusual Activities on The Dow at Bloomberg
12:48PM  US stocks fluctuate; S&P 500 near milestone at CNBC
11:34AM  [video] Facebook and Movado Downgraded, Deutsche Initiates Drugmakers at TheStreet
11:25AM  Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline Benzinga
11:11AM  US stocks fluctuate; S&P 500 near milestone at CNBC
11:00AM  [video] Merck & Pfizer team up at CNBC
10:39AM  US stocks fluctuate; S&P 500 near milestone at CNBC
10:26AM  Stocks edge mostly lower; S&P 500 dips below 2,000 at CNBC
09:59AM  [video] MassChallenge CEO Says Future is Bright for U.S. Entrepreneurship at TheStreet
09:09AM  Will This New Rating Help Pfizer (PFE) Stock Today? at TheStreet
26-Aug-14 04:10PM  Stocks rise; S&P 500 scores first finish above 2,000 at CNBC
12:46PM  Midday movers: Ann, Best Buy Co., Exxon & more at CNBC
12:07PM  Merck, Pfizer Combining Drugs In Lung Cancer Study at Investor's Business Daily
09:07AM  Pfizer to test Xalkori lung cancer drug with Merck immunotherapy Reuters
09:02AM  Stock futures hold mild gains amid economic reports at CNBC
08:42AM  [$$] Pfizer, Merck Team Up on Cancer Study at The Wall Street Journal
08:00AM  Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen Business Wire
03:16AM  Pfizer/AstraZeneca: Ready for round 2? at CNBC
25-Aug-14 03:14PM  [video] Whats Behind the Surge in Pharmaceutical Deals? at Bloomberg
02:07PM  Business events scheduled for Tuesday AP
01:24PM  Why Jim Cramer Thinks Merck (MRK), Pfizer (PFE), GlaxoSmithKline (GSK) Bids Are Coming After InterMune (ITMN) Deal at TheStreet
12:10PM  [video] Jim Cramer Says Roche's "Bolt-On" Acquisition Means Big Pharma is Thinking Big at TheStreet
09:06AM  [video] Roche's $8.3 billion deal for InterMune at CNBC
09:00AM  Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection PR Newswire
24-Aug-14 09:26PM  Roche's InterMune Acquisition Underscores How It And Pfizer Are On Different M&A Paths at Forbes
22-Aug-14 04:55PM  Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod Zacks
03:46PM  ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection PR Newswire
02:24PM  Glaxo, Pfizers ViiV Wins Approval for HIV Combo Drug at Bloomberg
09:00AM  Heart Doctor Pay Drops To $558K As Interventions Scrutinized at Forbes
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd. to develop population health management platform with advanced analytics and patient care capabilities. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Option Exercise26.2092,0002,410,400152,447Nov 18 03:31 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Sale32.1092,0002,953,06360,447Nov 18 03:31 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerNov 01Sale31.2010,000311,985174,841Nov 04 03:59 PM
READ IAN CChairman & CEOOct 28Option Exercise26.20338,0008,855,6001,412,267Oct 29 05:44 PM
READ IAN CChairman & CEOOct 28Sale30.57338,00010,331,3151,074,267Oct 29 05:44 PM